Metabolic phenotyping of blood plasma allows for the detection of lung cancer

Metabolic phenotyping of blood plasma by proton nuclear magnetic resonance identified unique metabolic biomarkers specific to lung cancer patients and allowed for the accurate identification of a cohort of patients with early and late-stage lung cancer.